About: Cytarabine     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Cytarabine
rdfs:subClassOf
Has_Salt_Form
Concept_In_Subset
Semantic_Type
  • Pharmacologic Substance
  • Nucleic Acid, Nucleoside, or Nucleotide
Preferred_Name
  • Cytarabine
NSC_Code
  • 287459
UMLS_CUI
  • C0010711
CAS_Registry
  • 147-94-4
Accepted_Therapeutic_Use_For
  • Meningeal leukemia; Acute Myeloid Leukemia; Meningitis lymphomatous; Myelodysplasic syndrome; Non-Hodgkins lymphoma; Ovarian cancer, intraperitoneal treatment; Retinoblastoma
  • Acute lymphocytic leukemia; Acute Nonlymphocytic leukemia; Bone marrow transplantation; Carcinomatous meningitis; Chronic myelogenous leukemia; Hogkins disease;
In_Clinical_Trial_For
  • Leukemia; Lymphoma; Meningeal Neoplasms
FDA_UNII_Code
  • 04079A1RDZ
Contributing_Source
  • FDA
ALT_DEFINITION
  • A drug used to treat certain types of leukemia and prevent the spread of leukemia to the meninges (three thin layers of tissue that cover and protect the brain and spinal cord). It is also being studied in the treatment of other types of cancer. Cytarabine blocks tumor growth by stopping DNA synthesis. It is a type of antimetabolite.NCI-GLOSS
PDQ_Open_Trial_Search_ID
  • 39015
PDQ_Closed_Trial_Search_ID
  • 39015
Chemical_Formula
  • C9H13N3O5
Legacy_Concept_Name
  • Cytosine_Arabinoside
CHEBI_ID
  • CHEBI:28680
FULL_SYN
  • AracytidineSYDTPNSC0287459
  • ArabinosylcytosineSYDTPNSC0287459
  • AracytidineSYNCI
  • CytarabinumSYNCI
  • cytarabinePTNCI-GLOSSCDR0000045155
  • 1-Beta-D-arabinofuranosylcytosineSNNCI
  • Tarabine PFSBRNCI
  • .beta.-Cytosine arabinosideSYDTPNSC0287459
  • Cytosine-.beta.-arabinosideSYDTPNSC0287459
  • 1.beta.-D-ArabinofuranosylcytosineSYDTPNSC0287459
  • 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-SYDTPNSC0287459
  • ArabinofuranosylcytosineSYNCI
  • U 19920SYDTPNSC0063878
  • Beta-Cytosine ArabinosideSYNCI
  • 1-.beta.-D-ArabinofuranosylcytosineSYDTPNSC0287459
  • CytosarSYDTPNSC0287459
  • Ara-CABNCI
  • Cytosine ArabinosidePTDCP01949
  • AlexanFBNCI
  • UdicilFBNCI
  • U-19920CNNCI
  • ArabinosylcytosineSYNCI
  • ArabineFBNCI
  • ErpalfaFBNCI
  • CytosarFBNCI
  • CYTARABINEPTFDA04079A1RDZ
  • CHX-3311CNNCI
  • WR-28453CNNCI
  • ARA-cellFBNCI
  • CytarbelFBNCI
  • AracytinFBNCI
  • StarasidFBNCI
  • ArabinofuranosylcytosineSYDTPNSC0287459
  • Cytosar-UBRNCI
  • AracytineFBNCI
  • 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinoneSNNCI
  • CytarabinePTNCI
  • 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinoneSYDTPNSC0287459
DEFINITION
  • An antimetabolite analogue of cytidine with a modified sugar moiety (arabinose instead of ribose). Cytarabine is converted to the triphosphate form within the cell and then competes with cytidine for incorporation into DNA. Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle. This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair. (NCI04)NCI
code
  • C408
is someValuesFrom of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 112 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software